Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality
- PMID: 28152067
- PMCID: PMC5289427
- DOI: 10.1371/journal.pone.0170236
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality
Abstract
We aimed to describe the characteristics of patients with Staphylococcus aureus bacteremia and to evaluate the risk factors associated with early (7-day) and late (30-day) mortality. We performed an observational study including all consecutive episodes of Staphylococcus aureus bacteremia diagnosed at two Italian university hospitals during 2010-2014. A total of 337 patients were included. Mean age was 69 years (range, 57-78) and 65% were males. Methicillin-resistant S. aureus (MRSA) was identified in 132/337 (39%)cases. Overall 7- and 30-day mortality were 13% and 26%, respectively. Early mortality was associated with increased Charlson scores (OR 1.3, 95% CI 1.1-1.5), MRSA bacteremia (OR 3.2, 95% CI 1.4-8.1), presentation with septic shock (OR 13.5, 95% CI 5.4-36.4), and occurrence of endocarditis (OR 4.5, 95%CI 1.4-14.6). Similar risk factors were identified for late mortality, including increased Charlson scores (OR 1.2, 95% CI 1.1-1.4), MRSA bacteremia (OR 2.1, 95% CI 1.2-3.9), presentation with septic shock (OR 4, 95%CI 1.7-9.7), occurrence of endocarditis (OR 3.8, 95% CI 1.4-10.2) as well as Child C cirrhosis (OR 3.9, 95% CI 1.1-14.4) and primary bacteremia (OR 2.5, 95%CI 1.3-5). Infectious disease consultation resulted in better outcomes both at 7 (OR 0.1, 95% CI 0.05-0.4) and at 30 days (OR 0.4, 95% CI 0.2-0.7). In conclusion, our study highlighted high rates of MRSA infection in nosocomial Staphylococcus aureus bacteremia. Multiple comorbidities, disease severity and methicillin-resistance are key factors for early and late mortality in this group. In patients with Staphylococcus aureus bacteremia, infectious disease consultation remains a valuable tool to improve clinical outcome.
Conflict of interest statement
The authors have declared no competing interests exist.
Similar articles
-
Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.Clin Microbiol Infect. 2013 Jul;19(7):E291-7. doi: 10.1111/1469-0691.12169. Epub 2013 Mar 13. Clin Microbiol Infect. 2013. PMID: 23490021
-
High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26. Int J Antimicrob Agents. 2012. PMID: 22633565
-
Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain.Infect Control Hosp Epidemiol. 2006 Nov;27(11):1219-25. doi: 10.1086/507924. Epub 2006 Sep 29. Infect Control Hosp Epidemiol. 2006. PMID: 17080380
-
Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.Korean J Intern Med. 2019 Nov;34(6):1347-1362. doi: 10.3904/kjim.2017.098. Epub 2018 Jan 20. Korean J Intern Med. 2019. PMID: 29347812 Free PMC article.
-
The Golden Grapes of Wrath - Staphylococcus aureus Bacteremia: A Clinical Review.Am J Med. 2023 Jan;136(1):19-26. doi: 10.1016/j.amjmed.2022.09.017. Epub 2022 Sep 28. Am J Med. 2023. PMID: 36179908 Review.
Cited by
-
Response patterns of routinely measured inflammatory and coagulatory parameters in sepsis.PeerJ. 2019 Jun 21;7:e7147. doi: 10.7717/peerj.7147. eCollection 2019. PeerJ. 2019. PMID: 31275752 Free PMC article.
-
Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.Antimicrob Agents Chemother. 2018 Jan 25;62(2):e01554-17. doi: 10.1128/AAC.01554-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29133561 Free PMC article.
-
β-Lactam Antibiotics with a High Affinity for PBP2 Act Synergistically with the FtsZ-Targeting Agent TXA707 against Methicillin-Resistant Staphylococcus aureus.Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00863-17. doi: 10.1128/AAC.00863-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28630190 Free PMC article.
-
Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia.BMC Infect Dis. 2025 Feb 18;25(1):231. doi: 10.1186/s12879-025-10620-3. BMC Infect Dis. 2025. PMID: 39966757 Free PMC article.
-
[Clinical characteristics and prognosis of Staphylococcus aureus bacteremia].Rev Esp Quimioter. 2022 Dec;35(6):544-550. doi: 10.37201/req/035.2022. Epub 2022 Oct 7. Rev Esp Quimioter. 2022. PMID: 36205230 Free PMC article. Spanish.
References
-
- 2014. EAArotEARSNE-N.
-
- Center for Disease Dynamics EP. State of the World’s Antibiotics CW, DC 2015.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical